# Sulfadoxine-pyrimethamine Plus Dihydroartemisinin-piperaquine for Intermittent Preventive Treatment in Pregnancy

> **NCT05426434** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Menzies School of Health Research** · enrollment: 1172 (estimated)

## Conditions studied

- Malaria
- Malaria in Pregnancy
- Pregnancy Related

## Interventions

- **DRUG:** Dihydroartemisinin-Piperaquine (DP)
- **DRUG:** Sulfadoxine pyrimethamine (SP)

## Key facts

- **NCT ID:** NCT05426434
- **Lead sponsor:** Menzies School of Health Research
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-08-31
- **Primary completion:** 2025-03-31
- **Final completion:** 2025-12
- **Target enrollment:** 1172 (ESTIMATED)
- **Last updated:** 2025-06-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05426434

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05426434, "Sulfadoxine-pyrimethamine Plus Dihydroartemisinin-piperaquine for Intermittent Preventive Treatment in Pregnancy". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT05426434. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*